Solid Dosage
GEA can supply the right technology for Manufacturing Solid Dosage Forms for Gastrointestinal Applications, incl. high-volume production, effervescent processing and MUPS.
Comprising a varied landscape of antacids, antiulcerants, vitamins and minerals, antiemetics, antinauseants, antidiarrheals and anti-obesity products, the gastrointestinal drugs market is segmented into a variety of oral solid dosage forms that require a wide range of different production techniques.
For example, for products that have to act in the stomach, effervescent dosages are often preferred. By contrast, for products that have to act in the intestines, MUPS or coated tablets are more prevalent.
Many of these products have to be produced in high volumes as they represent a large portion of the over-the-counter (OTC) market.
Whatever your application, GEA can supply the right equipment and technology for your production requirements: from integrated granulation lines for high-volume production and single-pot processors adapted to effervescent processing to tablet presses that can handle MUPS or effervescent formulations.
For coating applications, available technologies include fluid bed coating for smaller particles, such as powders, granules, seeds, crystals, pellets and small tablets, a multipurpose processor that uses proven fluid bed technology to achieve granulation, drying and pellet coating (or tablet coating) in a single processor and a continuous tablet coater that accurately deposits controlled amounts of coating materials on tablets, even if they are hygroscopic or friable.
Visualizzazione di 4 su 26

Ci occupiamo di integrazione di sistemi, e per farlo integriamo i prodotti software forniti dai leader di mercato con le conoscenze che abbiamo acquisito nel campo della tecnologia di processo e dell'ingegneria degli impianti.

Contained Materials Handling solutions for Primary and Secondary Pharmaceuticals and Healthcare. With extensive experience within the generics sector, supply a wide range of technologies and equipment that improve and enhance the efficiency and performance of Oral Solid Dosage production.

The ConsiGma® DC for direct compression is the latest expansion of GEA's continuous portfolio for cost effective, compact, high yield manufacturing systems. It offers a robust and flexible manufacturing method for a wide range of products.
Continuous Processing is becoming more and more important in the pharmaceutical industry. GEA takes the lead in introducing this innovative technology with ConsiGma® - continuous high-shear granulation and drying lines.

Mentre la domanda dei consumatori per le bevande più innovative nel settore della salute e del benessere continua a evolversi e a crescere, GEA aiuta i produttori a lanciare sul mercato nuovi prodotti in modo sicuro, efficiente e su larga scala.

Al settore manifatturiero viene richiesto di utilizzare meno risorse, puntare su tecnologie avanzate e mantenere le attrezzature in piena efficienza più a lungo. In GEA, questo sta cambiando il modo in cui nasce l’innovazione: ingegneria, comprensione delle esigenze dei clienti, competenze digitali e assistenza si integrano sin dalle prime fasi, quando una soluzione può ancora essere plasmata nella sua essenza.